Dr. Anna Veiga’s project to improve genetic edition of human embryos receives Merck Research Grant
The project aims to develop the CRISPR/Cas9 genetic edition technique in human embryos to study their development
The project aims to develop the CRISPR/Cas9 genetic edition technique in human embryos to study their development
The stem cell-based platform would enable a more accurate diagnosis of the disease, as it would detect with high precision a wide range of autoantibodies.
Sebastià tested positive for COVID-19 on March 24, and in this interview, he tells us how he has lived the confinement since then and the reflections he has reached.
A study led by IDIBELL researchers and published in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.
Nutrient deficiency in tumor cells attracts cells that suppress the immune system Read More »
Depending on the levels of illumination, the enzyme IMPDH1 is regulated at many levels, allowing to adapt the excitability of the photoreceptors.
Regulatory pathways unveiled for a key enzyme in retinal photoreceptor cell physiology Read More »
The projects include new therapies, the use of commercialized drugs for other indications and genetic studies, and some could reach the population before the end of the year.
The IDIBELL and the Bellvitge University Hospital projects are led by the groups of Dr. Jordi Carratalá, Dr. Rafael Mañez, and Dr. Xavier Solanich.
The call has been promoted by the General Directorate of Research and Innovation in Health (DGRI) with the collaboration of AQuAS and Biocat.
The health department will finance 3 IDIBELL’s projects on COVID-19 Read More »